Landry, I., Aluri, J., Hall, N., Filippov, G., Dayal, S., Moline, M., & Reyderman, L. (2021). Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant. Pharmacology research & perspectives, 9(2), e00734-n/a. https://doi.org/10.1002/prp2.734
Chicago Style (17th ed.) CitationLandry, Ishani, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Satish Dayal, Margaret Moline, and Larisa Reyderman. "Effect of Severe Renal Impairment on Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacology Research & Perspectives 9, no. 2 (2021): e00734-n/a. https://doi.org/10.1002/prp2.734.
MLA (9th ed.) CitationLandry, Ishani, et al. "Effect of Severe Renal Impairment on Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacology Research & Perspectives, vol. 9, no. 2, 2021, pp. e00734-n/a, https://doi.org/10.1002/prp2.734.